Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Unveiling Norseman: A Glimpse into Fiercely Reliable Fabric Buildings | Ron Bryant - CEO at Norseman
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Ron Bryant is the CEO at Norseman
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Collins Aerospace Retirement Benefits: A Comprehensive Guide
00:10:00
Mr. Joseph Bugeja, Chairman and CEO of Transport Malta, discusses a metro system proposal in a public interview.
00:10:00
Creso Pharma Switzerland: CBD related research development and commercialization|Boaz Wachtel,Chairman,Creso Pharma Ltd
00:10:00
Ben Arnold’s Journey from UBS to Global Trading Expertise
00:10:00
focused on building solutions to problems concerning healthier living|Adam Besvinick,Founder and Managing Partner,Looking Glass Capital
00:10:00
Coret Task Force on K-12 Education: 16 Years of Policy Influence and Future Directions|Chester E. Finn Jr.
00:10:00
Dr. Clarence Moniba's Journey and Liberia's Historical Context|Clarence K. Moniba
00:10:00
Airborne Survey Operations: Insights from Bell Geospace's Mark Bagley
00:10:00
B2B fintech from the perspective of a seasoned investor and advice for fintechs|Jesse Wedler,General Partner,CapitalG
00:10:00
Fiona Dawson on Embracing a Dynamic Mining Career and Promoting Diversity at Newmont
00:10:00
Understanding 401(k) Rollovers: When to Move Your Retirement Funds
00:10:00
Venture Capital is like a TV Series|Alex Menn, Partner, Begin Capital